scholarly journals A Phase 1 Study of ANB020, an anti-IL-33 monoclonal Antibody in Healthy Volunteers

2017 ◽  
Vol 139 (2) ◽  
pp. AB73 ◽  
Author(s):  
Marco Londei ◽  
Brian Kenney ◽  
Gerrit Los ◽  
Margaret H. Marino
Keyword(s):  
Monoclonal Antibody ◽  
Healthy Volunteers ◽  
Phase 1 ◽  
Phase 1 Study

scholarly journals A Phase 1 Study of PAmAb, a Fully Human Monoclonal Antibody against Bacillus anthracis Protective Antigen, in Healthy Volunteers

2005 ◽  
Vol 41 (1) ◽  
pp. 12-20 ◽  
Author(s):  
G. M. Subramanian ◽  
P. W. Cronin ◽  
G. Poley ◽  
A. Weinstein ◽  
S. M. Stoughton ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Healthy Volunteers ◽  
Bacillus Anthracis ◽  
Protective Antigen ◽  
Phase 1 ◽  
Human Monoclonal Antibody ◽  
Phase 1 Study

scholarly journals Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers

2021 ◽  
Vol 9 (2) ◽  
Author(s):  
Mohammad Al‐Mahdi Al‐Karagholi ◽  
Jakob Møller Hansen ◽  
Dalia Abou‐Kassem ◽  
Anna Koldbro Hansted ◽  
Kumari Ubhayasekera ◽  
...  
Keyword(s):  
Healthy Volunteers ◽  
Phase 1 ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Phase 1 Study

scholarly journals Phase 1 study of MEDI0562, a humanized OX40 agonist monoclonal antibody (mAb), in adult patients (pts) with advanced solid tumors

2016 ◽  
Vol 27 ◽  
pp. vi361 ◽  
Author(s):  
B.S. Glisson ◽  
R. Leidner ◽  
R.L. Ferris ◽  
J. Powderly ◽  
N. Rizvi ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Solid Tumors ◽  
Phase 1 ◽  
Adult Patients ◽  
Advanced Solid Tumors ◽  
Phase 1 Study

scholarly journals Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease

2009 ◽  
Vol 50 (8) ◽  
pp. 1251-1259 ◽  
Author(s):  
N. Nelissen ◽  
K. Van Laere ◽  
L. Thurfjell ◽  
R. Owenius ◽  
M. Vandenbulcke ◽  
...  
Keyword(s):  
Alzheimer Disease ◽  
Healthy Volunteers ◽  
Phase 1 ◽  
Phase 1 Study ◽  
Pittsburgh Compound B

scholarly journals A Phase 1 Study of Necitumumab (Anti-Egfr Monoclonal Antibody) in Japanese Patients with Advanced Solid Tumors

2014 ◽  
Vol 25 ◽  
pp. v70 ◽  
Author(s):  
Hiroshi Nokihara ◽  
Noboru Yamamoto ◽  
Yosuke Tamura ◽  
Yuko Tanabe ◽  
Kazunori Honda ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Solid Tumors ◽  
Phase 1 ◽  
Japanese Patients ◽  
Advanced Solid Tumors ◽  
Phase 1 Study
Sign in / Sign up

Export Citation Format

Share Document